| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |